The table below shows Benitec Biopharma Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$23.59M
-$19.40M
-$18.01M
-$15.90M
-$12.83M
-$7.54M
Capital expenditure
$18.00K
$179.00K
$1.00K
$13.00K
$221.00K
$95.00K
Investing cash flow
-$18.00K
-$179.00K
-$1.00K
-$13.00K
-$221.00K
-$94.00K
Dividends paid
-
-
-
-
BNTC operating cash flow (10-K history)
Benitec Biopharma Inc. reported operating cash flow of -$23.59M for fiscal year 2025. That is down 21.6% from -$19.40M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from $4.79M (FY 2019) to -$23.59M. Figures come from the company's audited annual reports as filed with the SEC.